U.S. Gene Expression Market Size & Outlook, 2022-2030
U.S. gene expression market, 2018-2030 (US$M)
Related Markets
U.S. gene expression market highlights
- The U.S. gene expression market generated a revenue of USD 5,257.4 million in 2022 and is expected to reach USD 7,763.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5% from 2023 to 2030.
- In terms of segment, cdna synthesis & conversion was the largest revenue generating process in 2022.
- Data Analysis & Interpretation is the most lucrative process segment registering the fastest growth during the forecast period.
Gene expression market data book summary
| Market revenue in 2022 | USD 5,257.4 million |
| Market revenue in 2030 | USD 7,763.5 million |
| Growth rate | 5% (CAGR from 2022 to 2030) |
| Largest segment | Cdna synthesis & conversion |
| Fastest growing segment | Data Analysis & Interpretation |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sample Collection, Purification, CDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation |
| Key market players worldwide | Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.6% of the global gene expression market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. gene expression market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 7,763.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Expression Market Scope
Gene Expression Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. gene expression market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene expression market will help companies and investors design strategic landscapes.
Cdna synthesis & conversion was the largest segment with a revenue share of 27.06% in 2022. Horizon Databook has segmented the U.S. gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
Collaborations between academic institutes and industry players are anticipated to drive the market in this country. For instance, in January 2016, it was reported that Genometry commercialized the high throughput gene expression assay developed by Harvard and Broad Institute of MIT.
These assays are considered to be significant tools in novel drug discovery for the pharmaceutical industry as they allow measurement of gene expression of cells to test drug response.
In addition, dominant players are acquiring emerging players from developing regions to expand their market reach. Adoption of various strategies by companies to sustain market competition within the country as well as around the world is anticipated to boost the market.
Reasons to subscribe to U.S. gene expression market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. gene expression market databook
-
Our clientele includes a mix of gene expression market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. gene expression market, including forecasts for subscribers. This country databook contains high-level insights into U.S. gene expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. gene expression analysis market size, by process, 2018-2030 (US$M)
U.S. Gene Expression Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
